Skip to main content
Top
Published in: Journal of Occupational Medicine and Toxicology 1/2006

Open Access 01-12-2006 | Hypothesis

Blood doping by cobalt. Should we measure cobalt in athletes?

Authors: Giuseppe Lippi, Massimo Franchini, Gian Cesare Guidi

Published in: Journal of Occupational Medicine and Toxicology | Issue 1/2006

Login to get access

Abstract

Background

Blood doping is commonplace in competitive athletes who seek to enhance their aerobic performances through illicit techniques.

Presentation of the hypothesis

Cobalt, a naturally-occurring element with properties similar to those of iron and nickel, induces a marked and stable polycythemic response through a more efficient transcription of the erythropoietin gene.

Testing the hypothesis

Although little information is available so far on cobalt metabolism, reference value ranges or supplementation in athletes, there is emerging evidence that cobalt is used as a supplement and increased serum concentrations are occasionally observed in athletes. Therefore, given the athlete's connatural inclination to experiment with innovative, unfair and potentially unhealthy doping techniques, cobalt administration might soon become the most suited complement or surrogate for erythropoiesis-stimulating substances. Nevertheless, cobalt administration is not free from unsafe consequences, which involve toxic effects on heart, liver, kidney, thyroid and cancer promotion.

Implications of the hypothesis

Cobalt is easily purchasable, inexpensive and not currently comprehended within the World Anti-Doping Agency prohibited list. Moreover, available techniques for measuring whole blood, serum, plasma or urinary cobalt involve analytic approaches which are currently not practical for antidoping laboratories. Thus more research on cobalt metabolism in athletes is compelling, along with implementation of effective strategies to unmask this potentially deleterious doping practice
Literature
1.
go back to reference Lippi G, Franchini M: The new frontiers of blood doping. Recenti Prog Med 2002, 93: 1–8.PubMed Lippi G, Franchini M: The new frontiers of blood doping. Recenti Prog Med 2002, 93: 1–8.PubMed
2.
go back to reference Lippi G, Franchini M, Guidi G: Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? Haematologica 2004, 89: ELT05.PubMed Lippi G, Franchini M, Guidi G: Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? Haematologica 2004, 89: ELT05.PubMed
3.
go back to reference Lippi G, Guidi G: Laboratory screening for erythropoietin abuse in sport: an emerging challenge. Clin Chem Lab Med 2000, 38: 13–19. 10.1515/CCLM.2000.003PubMedCrossRef Lippi G, Guidi G: Laboratory screening for erythropoietin abuse in sport: an emerging challenge. Clin Chem Lab Med 2000, 38: 13–19. 10.1515/CCLM.2000.003PubMedCrossRef
4.
go back to reference Lippi G, Montagnana M, Guidi GC: Albumin cobalt binding and ischemia modified albumin generation: An endogenous response to ischemia? Int J Cardiol 2006, 108: 410–411. 10.1016/j.ijcard.2005.03.040PubMedCrossRef Lippi G, Montagnana M, Guidi GC: Albumin cobalt binding and ischemia modified albumin generation: An endogenous response to ischemia? Int J Cardiol 2006, 108: 410–411. 10.1016/j.ijcard.2005.03.040PubMedCrossRef
5.
go back to reference Davis JE, Fields JP: Experimental production of polycythemia in humans by administration of cobalt chloride. Proc Soc Exp Biol Med 1958, 99: 493–495.PubMedCrossRef Davis JE, Fields JP: Experimental production of polycythemia in humans by administration of cobalt chloride. Proc Soc Exp Biol Med 1958, 99: 493–495.PubMedCrossRef
6.
go back to reference Wintrobe MM, Grinstein M, Dubash JJ, Humphreys SR, Ashenbrucker H, Worth W: The anemia of infection, VI. the influence of cobalt on the anemia associated with inflammation. Blood 1947, 2: 323–331.PubMed Wintrobe MM, Grinstein M, Dubash JJ, Humphreys SR, Ashenbrucker H, Worth W: The anemia of infection, VI. the influence of cobalt on the anemia associated with inflammation. Blood 1947, 2: 323–331.PubMed
7.
go back to reference Lippi G, Franchini M, Guidi GC: Cobalt chloride administration in athletes: a new perspective in blood doping? Br J Sports Med 2005, 39: 872–873. 10.1136/bjsm.2005.019232PubMedCentralPubMedCrossRef Lippi G, Franchini M, Guidi GC: Cobalt chloride administration in athletes: a new perspective in blood doping? Br J Sports Med 2005, 39: 872–873. 10.1136/bjsm.2005.019232PubMedCentralPubMedCrossRef
8.
go back to reference Speich M, Pineau A, Ballereau F: Minerals, trace elements and related biological variables in athletes and during physical activity. Clin Chim Acta 2001, 312: 1–11. 10.1016/S0009-8981(01)00598-8PubMedCrossRef Speich M, Pineau A, Ballereau F: Minerals, trace elements and related biological variables in athletes and during physical activity. Clin Chim Acta 2001, 312: 1–11. 10.1016/S0009-8981(01)00598-8PubMedCrossRef
10.
go back to reference Maughan RJ: Role of micronutrients in sport and physical activity. Br Med Bull 1999, 55: 683–690. 10.1258/0007142991902556PubMedCrossRef Maughan RJ: Role of micronutrients in sport and physical activity. Br Med Bull 1999, 55: 683–690. 10.1258/0007142991902556PubMedCrossRef
11.
go back to reference Lippi G, Guidi GC: Gene manipulation and improvement of athletic performances: new strategies in blood doping. Br J Sports Med 2004, 38: 641. 10.1136/bjsm.2004.013623PubMedCentralPubMedCrossRef Lippi G, Guidi GC: Gene manipulation and improvement of athletic performances: new strategies in blood doping. Br J Sports Med 2004, 38: 641. 10.1136/bjsm.2004.013623PubMedCentralPubMedCrossRef
12.
go back to reference Barceloux DG: Cobalt. Toxicol Clin Toxicol 1999, 37: 201–206. 10.1081/CLT-100102420CrossRef Barceloux DG: Cobalt. Toxicol Clin Toxicol 1999, 37: 201–206. 10.1081/CLT-100102420CrossRef
13.
go back to reference Linna A, Oksa P, Groundstroem K, Halkosaari M, Palmroos P, Huikko S, Uitti J: Exposure to cobalt in the production of cobalt and cobalt compounds and its effect on the heart. Occup Environ Med 2004, 61: 877–885. 10.1136/oem.2003.009605PubMedCentralPubMedCrossRef Linna A, Oksa P, Groundstroem K, Halkosaari M, Palmroos P, Huikko S, Uitti J: Exposure to cobalt in the production of cobalt and cobalt compounds and its effect on the heart. Occup Environ Med 2004, 61: 877–885. 10.1136/oem.2003.009605PubMedCentralPubMedCrossRef
14.
go back to reference World Anti-Doping Agency: The 2006 Prohibited List, International Standard. In The World Antidoping Code. WADA, Montreal; 2006. World Anti-Doping Agency: The 2006 Prohibited List, International Standard. In The World Antidoping Code. WADA, Montreal; 2006.
15.
go back to reference Ayala-Fierro F, Firriolo JM, Carter DE: Disposition, toxicity, and intestinal absorption of cobaltous chloride in male Fischer 344 rats. J Toxicol Environ Health A 1999, 56: 571–591. 10.1080/009841099157908PubMed Ayala-Fierro F, Firriolo JM, Carter DE: Disposition, toxicity, and intestinal absorption of cobaltous chloride in male Fischer 344 rats. J Toxicol Environ Health A 1999, 56: 571–591. 10.1080/009841099157908PubMed
16.
17.
go back to reference National Institute for Occupational Safety and Health: Cobalt. NIOSH pocket guide to chemical hazards 2000. Last Accessed: March 17, 2006 [http://www.cdc.gov] National Institute for Occupational Safety and Health: Cobalt. NIOSH pocket guide to chemical hazards 2000. Last Accessed: March 17, 2006 [http://​www.​cdc.​gov]
18.
go back to reference Aggarwal SK, Kinter M, Herold DA: Determination of cobalt in urine by gas chromatography-mass spectrometry employing nickel as an internal standard. J Chromatogr 1992, 576: 297–304.PubMedCrossRef Aggarwal SK, Kinter M, Herold DA: Determination of cobalt in urine by gas chromatography-mass spectrometry employing nickel as an internal standard. J Chromatogr 1992, 576: 297–304.PubMedCrossRef
19.
go back to reference Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, Gallick GE: HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005, 24: 3110–3120. 10.1038/sj.onc.1208513PubMedCrossRef Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, Gallick GE: HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005, 24: 3110–3120. 10.1038/sj.onc.1208513PubMedCrossRef
20.
go back to reference Singh NK, Chhabra R, Datta K: Nonenzymatic synthesis of delta-aminolevulinate (ALA) by cobalt (Co++). Biochem Biophys Res Commun 1987, 143: 439–446. 10.1016/0006-291X(87)91373-8PubMedCrossRef Singh NK, Chhabra R, Datta K: Nonenzymatic synthesis of delta-aminolevulinate (ALA) by cobalt (Co++). Biochem Biophys Res Commun 1987, 143: 439–446. 10.1016/0006-291X(87)91373-8PubMedCrossRef
Metadata
Title
Blood doping by cobalt. Should we measure cobalt in athletes?
Authors
Giuseppe Lippi
Massimo Franchini
Gian Cesare Guidi
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Journal of Occupational Medicine and Toxicology / Issue 1/2006
Electronic ISSN: 1745-6673
DOI
https://doi.org/10.1186/1745-6673-1-18

Other articles of this Issue 1/2006

Journal of Occupational Medicine and Toxicology 1/2006 Go to the issue